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IN PRACTICE
Systemic lupus erythematosus (SLE) is a multisystemic auto immune dis-
order, with neurological manifestations being common. Attribution 
of neurological features to SLE is often a challenging process that 
requires a thorough clinical evaluation, relevant laboratory investiga-
tions and imaging studies. Acute cerebellar ataxia has been described 
in SLE, although little has been published in this regard. Wernicke’s 
encephalopathy (WE) is a neurological complication of thiamine 
deficiency. Poor eating habits and vomiting are well-described causes 
of non-alcoholic WE. Gastrointestinal manifestations commonly 
occur, with nausea and vomiting reported in >50% of cases in some 
series. It is important that WE is considered in patients with SLE and 
ataxia, as it is treatable and carries a significant morbidity and mortal-
ity without appropriate treatment. 
Case report
A 24-year-old black female patient was referred to the rheumatology 
clinic at Dr George Mukhari Academic Hospital, a tertiary hospital 
in Pretoria, South Africa, with suspected SLE. Dermatologists had 
been treating her for a biopsy-proven bullous lupus for a few months. 
The initial consultation at the rheumatology clinic confirmed the 
diagnosis of SLE, based on the presence of acute cutaneous lupus, 
non-scarring generalised alopecia, haemolytic anaemia, positive 
antinuclear antibody, positive anti-Smith antibody, a weakly positive 
lupus anticoagulant test, and a low level of serum complement 3 
(C3), unequivocally fulfilling the Systemic Lupus International 
Collaborating Clinics  classification criteria for SLE.[1] Although her 
bullous lesions had healed, she had an active interarticular rash on 
her fingers and haemolytic anaemia, with a haemoglobin of 6.4 g/dL, 
confirming the presence of active disease. She received 2 U of blood 
and was treated with oral prednisone and oral azathioprine.
Five weeks later, she presented again, complaining of intermittent 
vomiting and nausea of ~3 weeks’ duration. She also reported weight 
loss and vertigo. A physical examination revealed sinus tachycardia, 
drowsiness, mild confusion, nystagmus, dysarthria, truncal and limb 
ataxia and bilateral partial 6th cranial nerve palsies. Her haemoglobin 
was 11.4 g/dL. All other laboratory tests for detecting active SLE in 
various organ systems were normal, except for hypoalbuminaemia, 
with a serum albumin of 26 g/L. Her renal function test was normal 
and there was no proteinuria. Hypoalbuminaemia seemed to reflect 
the severity of vomiting and possibly the negative acute-phase 
response. Typical features of SLE-related protein-losing enteropathy, 
such as diarrhoea, profound pitting oedema and effusions in serous 
cavities, were absent. Barium studies and gastroscopy did not show 
any abnormalities to explain the reasons for her vomiting, suggesting 
that SLE itself was the likely cause. SLE activity was thought to be 
the cause of sinus tachycardia, as other causes such as thyrotoxicosis, 
lung diseases, pulmonary embolism and myocarditis were excluded. 
With regard to her neurological symptoms and signs, the possibility 
of SLE-related cerebellar syndrome was initially considered in view 
of active SLE.
A computed tomography scan of the brain revealed cerebral 
atrophy, which is not an infrequent finding in patients with SLE. 
Subsequently, a lumbar puncture and analysis of the cerebrospinal 
fluid were normal, except for slightly elevated protein at 0.72 g/L; 
infection-related meningitis was excluded. Magnetic resonance imaging 
(MRI) scanning revealed signal hyperintensity in the thalami, mid-
line cerebellum and cerebellar hemispheres (Fig. 1). The clinical triad 
of mild confusion, ataxia and ophthalmoplegia in the presence of 
suggestive MRI findings led to the diagnosis of non-alcoholic WE. It 
was, however, considered an atypical presentation, as the patient had 
a pancerebellar syndrome involving the trunk and the limbs, rather 
than the typical midline cerebellar syndrome of WE that involves 
mainly the trunk. Dysarthria is also not a common clinical feature 
of WE.[2]
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We report a young woman with systemic lupus erythematosus (SLE) and an acute cerebellar ataxia. A history of poor appetite and vomiting 
preceded the inco-ordination. Ataxia in SLE has been well described, but is nevertheless uncommon. The clinical triad of mild confusion, 
ataxia and ophthalmoplegia also raised the possibility of Wernicke’s encephalopathy (WE). The diagnosis of WE was further supported 
by the magnetic resonance imaging features. Owing to overlapping causal factors, this case illustrates the complexity of diagnosing and 
managing neuropsychiatric syndromes in a patient with SLE. The limited published literature on SLE-related cerebellar syndromes adds 
to the challenge. Gastrointestinal manifestations of SLE are described as being common in SLE, with nausea and vomiting occurring in 
>50% of cases in some series. Poor eating habits and vomiting are well-described causes of non-alcoholic WE. This is the first description 
of gastrointestinal SLE as a possible cause of WE. 
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Case management
The patient was initially treated with intravenous fluid and empiric 
intravenous antibiotics. In view of the likelihood of gastrointestinal 
SLE, the low exclusion probability of SLE-related cerebellar syndrome, 
and low probability of sepsis, she was initially given three doses of 
intravenous methylprednisolone over 3 days at 750 mg/dose, followed 
by oral prednisone. Vomiting stopped after a few days. The patient 
was then started on high-dose intravenous thiamine for 2 weeks, 
followed by oral thiamine. Two weeks after the initiation of high-dose 
thiamine treatment, she was found to have some residual ataxia and 
confusion. Every 2 weeks six intravenous cyclophosphamide pulses at 
500 mg/dose were added to her treatment. 
Outcome and follow-up
At the completion of all six pulses of cyclophosphamide, the patient 
was assessed as being in remission from SLE, with no residual neuro-
logical features, except for mild forgetfulness reported by the patient. 
At her most recent follow-up visit about 1 year later, she remained in 
remission, with full neurological recovery.
Discussion
A major challenge in the diagnosis and management of the index 
patient was the decision to attribute her cerebellar ataxia to the SLE as 
opposed to an SLE-unrelated cause. This is not an uncommon chal-
lenge in the setting of neurological manifestations of SLE owing to 
an overlap in presentation. The main alternative diagnostic consider-
ation in this case was non-alcoholic WE.
The process of attributing a neuropsychiatric event to SLE usually 
involves: (i) exclusion of secondary causes; (ii) assessment of the type 
of event and its timing in relation to the onset of SLE; (iii) assessment 
of risk factors for SLE-related events v. SLE-unrelated events; (iv) spe-
cial investigations, often including neuroimaging and analysis of cere-
brospinal fluid; and (v) assessment of clinical response to treatment.[3] 
Secondary causes such as drugs, a paraneoplastic phenomenon 
and metabolic abnormalities causing cerebellar ataxia were excluded 
and no source of infection was identified. 
Regarding the type of event, it has been shown that major occur-
rences, such as an acute confusion state, refractory seizures, myelo-
pathy, optic neuritis, acute psychosis, polyneuropathy and stroke, 
are more likely to be attributable to SLE than minor events, such as 
mild depression, anxiety, headaches, mild cognitive dysfunction and 
polyneuropathy without electrophysiological evidence.[4] However, 
there is a scarcity of information about SLE-related cere bellar ataxia 
in the published literature. The American College of Rheumatology 
described 19 neuropsychiatric syndromes in 1999[5] – one of these 
is movement disorders. Cerebellar ataxia together with chorea and 
hemiballis mus are categorised as movement disorders. In 1988, 
Singh et al.[6] reported three women with SLE and cerebellar ataxia, 
who responded favourably to treatment with moderate doses of 
prednisone. In 1996, Manto et al.[7] reported a 27-year-old woman 
with SLE, who presented with a subacute pancerebellar syndrome. 
Her brain MRI scan showed cerebellar atrophy and the cerebellar 
ataxia improved markedly following corticosteroid administration. 
In 2000, Yaginuma et al.[8] described a 28-year-old woman with active 
SLE involving digestive tract, skin and kidneys, who developed acute 
cerebellar ataxia, a paresis of the right inferior rectus muscle, left 
abducens paralysis and left facial palsy, which seemed to be consistent 
with a brainstem lesion visible on MRI. This lesion disappeared within 
9 days of corticosteroid treatment. In 2008, Appenzeller et al.[9] reported 
3 women with SLE and acute cerebellar ataxia, who were successfully 
treated with intravenous corticosteroids and an immunosuppressant. 
Most recently, in 2014, Ghosh et al.[10] described a 22-year-old girl with 
active SLE, who presented with lupus nephropathy and subacute pan-
cerebellar syndrome. Her brain MRI scan showed cerebellar atrophy. 
Treatment of lupus nephropathy with oral corticosteroids and myco-
phenolate mofetil prevented further deterioration of her cerebellar 
syndrome. 
Regarding the timing of the event, an SLE-related neuropsychiatric 
event tends to occur at the onset of SLE or within the first 2 years after 
the diagnosis.[3] Our patient seemed to fall into the latter category. 
Major risk factors for SLE-related events include generalised SLE 
activity or damage, history of previous or concurrent major SLE-
related neuropsychiatric events and presence of antiphospholipid 
antibodies.[3] Our patient had a weakly positive lupus anticoagulant 
test. The following features may have suggested active SLE in this 
patient: sinus tachycardia, hypoalbuninaemia, low serum C3 level and 
possible gastrointestinal SLE.
MRI findings of our patient were not typical for an SLE-related 
neuropsychiatric event. There was no evidence of ischaemia, as would 
have resulted from a vasculitis or vasculopathy. The involvement of 
the vermis, the paravermis together with the medial aspects of both 
thalami, has been described by some researchers as specific for non-
alcoholic WE.[11,12] The involvement of the cerebellar hemispheres, 
albeit atypical, has been described in WE.[13]
Gastrointestinal manifestations are described as being common in 
SLE, with nausea and vomiting occurring in >50% of cases in some 
series.[14] In our patient, the acute cerebellar syndrome, together 
with the MRI features, was suggestive of WE. Poor eating habits and 
vomit ing are well-described causes of non-alcoholic WE.[15]
WE is a neurological complication of thiamine (vitamin B1) defi-
ciency.[2] It is an acute syndrome requiring emergent treatment to 
prevent death and neurological morbidity. Women appear to be more 
susceptible to the condition than men. Although chronic alcoholism 
accounts for most cases of WE, it can be associated with other condi-
tions such as anorexia nervosa, dieting, starvation, gastrointestinal 
surgery or hyperemesis gravidarum. The classic triad of encepha-
lopathy, oculomotor dysfunction/ophthalmoplegia and gait ataxia 
may not be present in all patients; hence, a high index of suspicion is 
necessary to recognise and treat the condition early. Ataxia of the legs 
or arms and dysarthria or scanning speech are thought to be uncom-
Fig. 1. Brain MRI fluid-attenuated inversion-recovery (FLAIR) images and 
diffusion-weighted images (DWI). (A) FLAIR image shows hyperintensity in 
cerebellar hemispheres (white arrows). (B) FLAIR image shows hyperintensity 
in cerebellar vermis and paravermis (black arrow head). (C) DWI shows hy-
perintensity in cerebellar hemispheres (void arrows). (D) DWI shows hyperin-
tensity in the thalami (black arrows).
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mon, although some literature suggests that the lower limbs are 
typically involved. Diagnosis is primarily clinical because the specific 
diagnostic laboratory tests (e.g. red blood cell thiamine) are often not 
readily available. A brain MRI scan typically shows signal hyperin-
tensities in the periaqueductal area, medial thalamus, dorsal medulla, 
tectal plate and mamillary bodies. Treatment of WE is essentially with 
high-dose intravenous thiamine, followed by oral thiamine. Response 
to thiamine replacement is usually very good and improvement in 
ocular signs and confusion can be seen within hours to days, while 
gait ataxia may start improving only in the second week.
Conclusion 
Owing to overlapping causal factors, this case illustrates the 
complexity of diagnosing and managing neuropsychiatric syndromes 
in patients with SLE. The limited published literature on SLE-related 
cerebellar syndrome further contributes to the diagnostic dilemma. 
Ataxia is not common in SLE; when it occurs, WE is an important 
consideration because it is treatable and carries a significant morta-
lity rate, should it be ignored.[16] In our case, given the clinical 
presentation, which was suggestive of WE owing to gastrointestinal 
SLE, we instituted treatment for both conditions, with a satisfactory 
outcome. This is the first description of gastrointestinal SLE as a 
possible cause of non-alcoholic WE.
Teaching points
•  Diagnosing and managing neuropsychiatric syndromes in patients 
with SLE is a challenging process, requiring a multidisciplinary 
approach.
•  Poor eating habits and vomiting are well-described causes of non-
alcoholic WE.
•  Gastrointestinal manifestations, such as vomiting, are common in 
SLE.
• Gastrointestinal SLE is a possible cause of non-alcoholic WE.
•  WE is an important consideration in a patient with SLE and acute 
cerebellar ataxia.
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